Detalles de la búsqueda
1.
Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study.
Thorac Cancer
; 14(31): 3147-3160, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704565
2.
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study.
Transl Lung Cancer Res
; 12(11): 2229-2244, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38090527
3.
[Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients â©Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: â©A Single-center Retrospective Study].
Zhongguo Fei Ai Za Zhi
; 25(3): 156-166, 2022 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-35340158
4.
Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey.
Asia Pac J Clin Oncol
; 18(5): e338-e345, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843160
5.
Characteristics and Clinical Implication of UGT1A1 Heterozygous Mutation in Tumor.
Zhongguo Fei Ai Za Zhi
; 25(3): 137-146, 2022 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35340156
6.
Clinical outcome, long-term survival and tolerability of sequential therapy of first-line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China.
Thorac Cancer
; 13(1): 107-116, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34851035
7.
Alectinib as first-line treatment for advanced ALK-positive non-small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort.
Transl Lung Cancer Res
; 11(12): 2495-2506, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636411
8.
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China.
Thorac Cancer
; 13(3): 412-422, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34935288
9.
Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis.
Life (Basel)
; 11(11)2021 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833153
10.
Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer.
Asia Pac J Oncol Nurs
; 8(5): 586-590, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34527790
11.
Value and significance of brain radiation therapy during first-line EGFR-TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique.
Thorac Cancer
; 12(23): 3157-3168, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651449
12.
Different patterns of treatment-related adverse events of programmed cell death-1 and its ligand-1 inhibitors in different cancer types: A meta-analysis and systemic review of clinical trials.
Asia Pac J Clin Oncol
; 16(5): e160-e178, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779383
13.
Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas.
J BUON
; 25(2): 927-932, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32521887
14.
[Retrospective Analysis of Risk Factors for Venous Thromboembolism in 283 Patients with Lung Cancer during Systemic Therapy].
Zhongguo Fei Ai Za Zhi
; 22(7): 419-426, 2019 Jul 20.
Artículo
en Zh
| MEDLINE | ID: mdl-31315780
15.
Transformation to small cell lung cancer and activation of KRAS during long-term erlotinib maintenance in a patient with non-small cell lung cancer: A case report.
Oncol Lett
; 17(6): 5219-5223, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31186738
16.
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
Thorac Cancer
; 10(7): 1521-1532, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144459
17.
[Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].
Zhongguo Fei Ai Za Zhi
; 21(3): 241-250, 2018 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29587953
18.
[Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi
; 21(6): 481-492, 2018 Jun 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29945708
19.
Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma.
Thorac Cancer
; 8(3): 159-169, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220630
Resultados
1 -
19
de 19
1
Próxima >
>>